1.	Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: WD 40, NCT00176046
2.	Phase III Randomized Trial of Adjuvant Treatment with IFN-A vs IFN-G vs Mistletoe Extract (Iscador M) vs No Further Treatment Following Curative Resection of High-Risk Stage I/IIB Malignant Melanoma (Summary Last Modified 11/93) Phase: Phase III Type: Treatment Status: Closed Age: 18 to 80 Sponsor: Protocol IDs: EORTC-DKG-80-1
3.	Phase II Study of Supplemental Treatment With Mistletoe in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Receiving Palliative Chemotherapy Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: TJUH-01F.45, TJUH-2001-35, NCT00052325
4.	Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: Mistletoe.ctil, NCT00516022
5.	Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: EORTC-16002, NCT00006354
6.	Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: EORTC-13001, NCT00006477
7.	Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 1056757, Mistletoe, NCT00283478